Related Experiment Videos
Molecular identification of Pasteurella dagmatis peritonitis in a patient undergoing peritoneal dialysis
F Wallet1, F Touré, A Devalckenaere
1Laboratoire de Bactériologie-Hygiène, Hôpital A. Calmette, CHRU de Lille, Lille, France. fwallet@chru-lille.fr
Abstract:
Pasteurella dagmatis was identified as the etiologic agent of peritonitis in a continuous ambulatory peritoneal dialysis patient by utilizing a molecular kit in our hospital's clinical laboratory. This method would appear a useful approach to identify a species of Pasteurella not included in the existing database of commercial identification kits when discrepancies exist between phenotypic tests.
Insights
A molecular kit identified Pasteurella dagmatis as the cause of peritonitis in a peritoneal dialysis patient. This method aids in identifying Pasteurella species not in commercial kits when tests conflict.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Clinical Diagnostics
Background:
- Continuous ambulatory peritoneal dialysis (CAPD) patients are susceptible to peritonitis.
- Accurate identification of causative pathogens is crucial for effective treatment.
- Standard microbiological methods may face limitations in identifying rare or atypical bacteria.
Observation:
- A case of peritonitis in a CAPD patient was investigated.
- A molecular identification kit was employed in the hospital's clinical laboratory.
- Phenotypic tests showed discrepancies, prompting the use of molecular methods.
Findings:
- Pasteurella dagmatis was identified as the specific etiologic agent of the peritonitis.
- The molecular kit successfully identified a Pasteurella species not present in existing commercial databases.
- This highlights the utility of molecular diagnostics beyond standard commercial offerings.
Implications:
- Molecular identification kits offer a valuable tool for diagnosing infections caused by less common pathogens.
- This approach can resolve ambiguities arising from phenotypic identification methods.
- Enhanced diagnostic capabilities can improve patient outcomes in CAPD-related infections.